{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:48:30Z","timestamp":1787500110442,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005492","name":"Stanford University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007150","name":"United Therapeutics Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","semthorcardiovascsurg.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1053\/j.semtcvs.2022.07.011","type":"journal-article","created":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T12:19:42Z","timestamp":1659442782000},"page":"733-743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Subcutaneous Treprostinil Improves Surgical Candidacy for Next Stage Palliation in Single Ventricle Patients With High-Risk Hemodynamics"],"prefix":"10.1053","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4580-9965","authenticated-orcid":false,"given":"Rachel T.","family":"Sullivan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie S.","family":"Handler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Feinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel K.","family":"Hopper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Norris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth A.","family":"Hollander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0576-0856","authenticated-orcid":false,"given":"Sharon","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semtcvs.2022.07.011_bib0001","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/apa.15098","article-title":"Providing a framework of principles for conceptualising the Fontan circulation","volume":"109","author":"Gewillig","year":"2020","journal-title":"Acta Paediatr"},{"key":"10.1053\/j.semtcvs.2022.07.011_bib0002","series-title":"Paediatric Cardiology: Churchill Livingstone","article-title":"Selection criteria for the Fontan procedure","author":"Choussat","year":"1977"},{"key":"10.1053\/j.semtcvs.2022.07.011_bib0003","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00246-010-9811-9","article-title":"Fontan \u201cTen Commandments\u201d revisited and revised","volume":"31","author":"Stern","year":"2010","journal-title":"Pediatr Cardiol"},{"key":"10.1053\/j.semtcvs.2022.07.011_bib0004","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.athoracsur.2015.11.047","article-title":"Survival in children with down syndrome undergoing single-ventricle palliation","volume":"101","author":"Colquitt","year":"2016","journal-title":"Ann Thorac Surg"},{"issue":"14_suppl_1","key":"10.1053\/j.semtcvs.2022.07.011_bib0005","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.107.751784","article-title":"Performance of cavopulmonary palliation at elevated altitude: midterm outcomes and risk factors for failure","volume":"118","author":"Malhotra","year":"2008","journal-title":"Circulation"},{"key":"10.1053\/j.semtcvs.2022.07.011_bib0006","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/ejcts\/ezr280","article-title":"Current outcomes of the Glenn bidirectional cavopulmonary connection for single ventricle palliation","volume":"42","author":"Alsoufi","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1053\/j.semtcvs.2022.07.011_bib0007","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.healun.2017.09.008","article-title":"Subcutaneous treprostinil in pediatric patients with failing single-ventricle physiology","volume":"37","author":"Handler","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/j.semtcvs.2022.07.011_bib0008","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.21037\/atm-21-3188","article-title":"Pharmacokinetics of treprostinil in children with functional single-ventricle pulmonary arterial hypertension: a randomized controlled trial","volume":"9","author":"Chen","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1053\/j.semtcvs.2022.07.011_bib0009","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1161\/01.CIR.85.2.469","article-title":"Five- to fifteen-year follow-up after Fontan operation","volume":"85","author":"Driscoll","year":"1992","journal-title":"Circulation"},{"key":"10.1053\/j.semtcvs.2022.07.011_bib0010","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0022-5223(96)70049-1","article-title":"Modified fontan operation in functionally univentricular hearts: Preoperative risk factors and intermediate results","volume":"112","author":"Kaulitz","year":"1996","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.semtcvs.2022.07.011_bib0011","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/S0022-5223(95)70208-3","article-title":"The modified fontan operation: an analysis of risk factors for early postoperative death or takedown in 702 consecutive patients from one institution","volume":"109","author":"Knott-Craig","year":"1995","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.semtcvs.2022.07.011_bib0012","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0022-5223(03)00117-X","article-title":"The modified fontan procedure: early and late results in 132 adult patients","volume":"125","author":"Burkhart","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.semtcvs.2022.07.011_bib0013","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1067\/mtc.2003.193","article-title":"Isra\u00ebl-Biet D. Nitric oxide synthase expression by pulmonary arteries: A predictive marker of Fontan procedure outcome?","volume":"125","author":"L\u00e9vy","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.semtcvs.2022.07.011_bib0014","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijcard.2011.02.021","article-title":"Overexpression of endothelin-1 and endothelin receptors in the pulmonary arteries of failed Fontan patients","volume":"159","author":"Ishida","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1053\/j.semtcvs.2022.07.011_bib0015","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.healun.2015.01.005","article-title":"Adverse pulmonary vascular remodeling in the Fontan circulation","volume":"34","author":"Ridderbos","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/j.semtcvs.2022.07.011_bib0016","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/eurheartj\/ehp036","article-title":"Effect of sildenafil on haemodynamic response to exercise and exercise capacity in Fontan patients: reply","volume":"30","author":"Giardini","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1053\/j.semtcvs.2022.07.011_bib0017","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/CIRCULATIONAHA.110.981746","article-title":"Impact of oral sildenafil on exercise performance in children and young adults after the fontan operation: a randomized, double-blind, placebo-controlled, crossover trial","volume":"123","author":"Goldberg","year":"2011","journal-title":"Circulation"},{"key":"10.1053\/j.semtcvs.2022.07.011_bib0018","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1161\/CIRCULATIONAHA.119.044352","article-title":"Results of the FUEL Trial","volume":"141","author":"Goldberg","year":"2020","journal-title":"Circulation"},{"key":"10.1053\/j.semtcvs.2022.07.011_bib0019","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1161\/CIRCULATIONAHA.113.008441","article-title":"Bosentan improves exercise capacity in adolescents and adults after fontan operation: the tempo (treatment with endothelin receptor antagonist in fontan patients, a randomized, placebo-controlled, double-blind study measuring peak oxygen consumption) study","volume":"130","author":"Hebert","year":"2014","journal-title":"Circulation"},{"key":"10.1053\/j.semtcvs.2022.07.011_bib0020","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.1111\/chd.12189","article-title":"Efficacy of endothelin blockade in adults with fontan physiology","volume":"10","author":"Derk","year":"2015","journal-title":"Congenital Heart Dis"},{"key":"10.1053\/j.semtcvs.2022.07.011_bib0021","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.amjcard.2016.02.024","article-title":"Effect of Ambrisentan on Exercise Capacity in Adult Patients After the Fontan Procedure","volume":"117","author":"Cedars","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.semtcvs.2022.07.011_bib0022","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4103\/rcm.rcm_18_17","article-title":"Tadalafil and exercise capacity after fontan operation","volume":"7","author":"Khajali","year":"2018","journal-title":"Res Cardiovasc Med"},{"key":"10.1053\/j.semtcvs.2022.07.011_bib0023","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijcard.2016.06.322","article-title":"Sildenafil reduces pulmonary vascular resistance in single ventricular physiology","volume":"221","author":"Mori","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1053\/j.semtcvs.2022.07.011_bib0024","doi-asserted-by":"crossref","DOI":"10.1007\/s00246-020-02424-w","article-title":"Pulmonary vasodilator therapy in children with single ventricle physiology: effects on saturation and pulmonary arterial pressure","author":"Jeremiasen","year":"2020","journal-title":"Pediatr Cardiol"},{"key":"10.1053\/j.semtcvs.2022.07.011_bib0025","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1161\/CIR.0000000000000329","article-title":"Pediatric pulmonary hypertension: guidelines from the american heart association and american thoracic society","volume":"132","author":"Abman","year":"2015","journal-title":"Circulation"},{"key":"10.1053\/j.semtcvs.2022.07.011_bib0026","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01916-2018","article-title":"Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management","volume":"53","author":"Rosenzweig","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1053\/j.semtcvs.2022.07.011_bib0027","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1161\/01.CIR.99.9.1197","article-title":"Vasodilator therapy for primary pulmonary hypertension in children","volume":"99","author":"Barst","year":"1999","journal-title":"Circulation"},{"key":"10.1053\/j.semtcvs.2022.07.011_bib0028","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.healun.2013.01.1055","article-title":"Children with pulmonary arterial hypertension and prostanoid therapy: Long-term hemodynamics","volume":"32","author":"Siehr","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/j.semtcvs.2022.07.011_bib0029","doi-asserted-by":"crossref","first-page":"e13742","DOI":"10.1111\/petr.13742","article-title":"Treprostinil improves hemodynamics and symptoms in children with mild pulmonary hypertension awaiting heart transplantation","volume":"24","author":"Hollander","year":"2020","journal-title":"Pediatr Transplant"},{"key":"10.1053\/j.semtcvs.2022.07.011_bib0030","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijcard.2018.03.067","article-title":"Safety, efficacy and Management of subcutaneous treprostinil infusions in the treatment of severe pediatric pulmonary hypertension","volume":"264","author":"Levy","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1053\/j.semtcvs.2022.07.011_bib0031","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1086\/674762","article-title":"Safety of epoprostenol and treprostinil in children less than 12 months of age","volume":"3","author":"McIntyre","year":"2013","journal-title":"Pulm Circ"}],"container-title":["Seminars in Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043067922001915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043067922001915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:34:21Z","timestamp":1760906061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043067922001915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"alternative-id":["S1043067922001915"],"URL":"https:\/\/doi.org\/10.1053\/j.semtcvs.2022.07.011","relation":{},"ISSN":["1043-0679"],"issn-type":[{"value":"1043-0679","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subcutaneous Treprostinil Improves Surgical Candidacy for Next Stage Palliation in Single Ventricle Patients With High-Risk Hemodynamics","name":"articletitle","label":"Article Title"},{"value":"Seminars in Thoracic and Cardiovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semtcvs.2022.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}